Farmak

Farmak is a leader in the production of pharmaceuticals in Ukraine and a leading exporter of national products to markets in over 50 countries around the world. High quality and constant innovation allow the company to maintain its leadership for more than 13 years.

Farmak exports medicines to over 50 countries around the world. Among them are EU countries, as well as Cambodia, Colombia, Chile, Indonesia, Australia, and even New Zealand.

Farmak’s product portfolio includes more than 450 drug names, which are manufactured at a high-tech enterprise in accordance with strict European requirements of Good Manufacturing Practice (GMP). GMP is a part of the quality assurance system, a guarantee that pharmaceutical products are manufactured and controlled according to quality standards and in accordance with the marketing authorization. Among Ukrainian pharmaceutical companies, Farmak has the largest number of GMP certificates issued by European regulators.

In the summer of 2023, Farmak increased its presence in EU countries by acquiring marketing pharmaceutical companies in the Czech Republic and Slovakia.

Farmak has representative offices in Uzbekistan, Kazakhstan, Kyrgyzstan, Vietnam, the Czech Republic, Slovakia, and Poland, as well as an international office in the UAE, and has for the first time exported to the Republic of South Africa (RSA). Now, antibacterial eye drops of Ukrainian production can be purchased in the RSA.